跳至主要内容
临床试验/CTRI/2021/01/030352
CTRI/2021/01/030352尚未招募未知

se of pyruvate kinase M1 and M2 biomarker in predicting coexistent carcinoma endometrium, in cases of atypical endometrial hyperplasia, to facilitate choice of fertility sparing surgery

Research committee0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Histopathological diagnosis of atypical endometrial hyperplasia on endometrial biopsy specimen
  • 2.Patient willing to undergo hysterectomy
  • 3.Final diagnosis of endometrial carcinoma on hysterectomy specimen.
  • 4.Willing to participate in the study
  • 1.Histopathological diagnosis of atypical endometrial hyperplasia on endometrial biopsy specimen
  • 2.Patient willing to undergo hysterectomy
  • 3.Final diagnosis of AEH on hysterectomy specimen.
  • 4.Willing to participate in the study

排除标准

  • 1.Patients not willing for hysterectomy
  • 2.Received medical treatment before surgery
  • 1.Patients not willing for hysterectomy
  • 2.Patients received medical treatment before surgery

研究者

发起方
Research committee

相似试验